One in a Billion
Clinical trials under way at four cancer-treatment centers in the U.S. may revolutionize the way the second-leading cause of death in the U.S. is treated.
Resveratrol Rescue?
The American Diabetes Association (ADA) has awarded $600,000 to the Albert Einstein College of Medicine of Yeshiva University to study the effects of resveratrol on prediabetes.
New Treatment for MS Approved in U.S., Europe
Pharmaceutical company Novartis AG's multiple sclerosis (MS) drug, Gilenya, has been approved for use in the United States and now Europe to treat relapsing-remitting forms of the disease.
It's All in Your Head
Glaucoma, a leading cause of blindness in the U.S., may not start in the optic nerve of the eye as previously believed. Researchers indicate the first sign of the disease may appear in the brain.
Endothelial Cells and Cancer Cells Duke It Out
MIT researchers have discovered that endothelial cells (cells in blood vessels) secrete molecules that inhibit tumor growth and deter cancer cells' invasion of other tissues.